Showing 1,523 results

Filters Content type: News, Editors' picks, About HIV Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Clinical trials

How to Tell When A Drug Company Fibs About Clinical Trial Results

Editor's pick
The Street
4 July 2012
Pharmaceutical industry

Tanzania: Muhas Develops Anti-Retroviral Formula

Editor's pick
AllAfrica
3 July 2012
Access to healthcare

Activists in the EECA demand a tenfold reduction of the price for pegylated interferons

Editor's pick
EATG
2 July 2012
Pharmaceutical industry

HIV generics take over the antivirals market

Editor's pick
GBI Research
2 July 2012
Global health initiatives

Gates Foundation readies a round of tempting biotech investments

Editor's pick
Fierce Biotech
2 July 2012
New & experimental hepatitis C treatment

Medivir announces an interferon-free phase II combination trial of hepatitis C drugs TMC435 and daclatasvir to commence shortly

Editor's pick
Medivir
29 June 2012
New & experimental HIV treatments

Gilead Sciences files for approval of cobicistat

Editor's pick
Bloomberg BusinessWeek
29 June 2012
PrEP science

The road to PrEP: trials, regulation and roll-out

News
25 June 2012
Access to healthcare

MEPs to 'finish off' ACTA on 4 July

Editor's pick
EurActiv
22 June 2012
Access to healthcare

If you can’t join ‘em, beat ‘em: new industry effort a jab at patent pool?

Editor's pick
Intellectual Property Watch
22 June 2012
Pharmaceutical industry

Roche did not report US patients’ deaths

Editor's pick
Financial Times
22 June 2012
New & experimental hepatitis C treatment

Idenix hep C drug shows promise in mid-stage study

Editor's pick
Reuters
20 June 2012
New & experimental HIV treatments

European Medicines Agency Validates Gilead ’s Marketing Application for Elvitegravir for Treatment of HIV Infection

Editor's pick
Gilead press release
19 June 2012
Pharmaceutical industry

AHF: Gilead Pulls AIDS Funding After AHF Advocacy Efforts

Editor's pick
Market Watch (press release)
15 June 2012
PrEP

FDA delays decision on drug to prevent HIV

Editor's pick
Washington Post
9 June 2012
Access to healthcare

China changes patent law in fight for cheaper drugs

Editor's pick
Reuters
9 June 2012
PrEP

FDA Moves Deadline for Approval of Truvada as PrEP to September

Editor's pick
Mapping Pathways
8 June 2012
Access to healthcare

South Africa: Addressing Tenofovir Shortages

Editor's pick
AllAfrica
8 June 2012
Pharmaceutical industry

The business of HIV: a huge, strange drug market

Editor's pick
The Economist
1 June 2012
Pharmaceutical industry

Vertex Goes From Bad Data To A Bad Promotion

Editor's pick
Pharmalot
1 June 2012
Access to healthcare

South Africa: Tenofovir Shortages Continue

Editor's pick
AllAfrica
31 May 2012
Hepatitis C treatment

FDA says Vertex promotional material overstates benefits of hepatitis C drug

Editor's pick
Boston Globe
31 May 2012
New & experimental hepatitis C treatment

GSK seeks to expand low-platelet drug Promacta to hepatitis C patients

Editor's pick
MedCity News
31 May 2012
HIV treatment

FDA turns down higher dosage for HIV drug Prezista

Editor's pick
Med City News
30 May 2012